ConductScience.org, home

Paper42985589PubMed

Exploration of the Pathogenesis and Treatment of Heart Failure.

Wen B and 2 others. Rev Cardiovasc Med, 2026.

Cite this record

ConductScience Library. Exploration of the Pathogenesis and Treatment of Heart Failure. Papers, record 42985589. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42985589

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exploration of the Pathogenesis and Treatment of Heart Failure.
Journal
Rev Cardiovasc Med
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-11-06

Source PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References134

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140521614The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC.Eur J Heart Fail2025https://conductscience.org/library/papers/40521614PubMed
241462938Cellular and Molecular Mechanisms of Heart Failure and Sudden Cardiac Death in Hypertrophic Cardiomyopathy and Methods Used for Their Pathogenetic Correction.Biomedicines2025https://conductscience.org/library/papers/41462938PubMed
337623365Autophagy in Heart Failure: Insights into Mechanisms and Therapeutic Implications.J Cardiovasc Dev Dis2023https://conductscience.org/library/papers/37623365PubMed
440931092Heart failure-specific cardiac fibroblasts contribute to cardiac dysfunction via the MYC-CXCL1-CXCR2 axis.Nat Cardiovasc Res2025https://conductscience.org/library/papers/40931092PubMed
540318256Valine acts as an early biomarker and exacerbates pathological cardiac hypertrophy by impairing mitochondrial quality control.Atherosclerosis2025https://conductscience.org/library/papers/40318256PubMed
639225278Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.N Engl J Med2024https://conductscience.org/library/papers/39225278PubMed
740892608Pharmacologic Treatment of Heart Failure With Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-Analysis.J Am Coll Cardiol2025https://conductscience.org/library/papers/40892608PubMed
834922348The 'Ten Commandments' of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur Heart J2022https://conductscience.org/library/papers/34922348PubMed
940022104Complex regulation of cardiac fibrosis: insights from immune cells and signaling pathways.J Transl Med2025https://conductscience.org/library/papers/40022104PubMed
1038616546Ca2+/calmodulin-dependent kinase IIδC-induced chronic heart failure does not depend on sarcoplasmic reticulum Ca2+ leak.ESC Heart Fail2024https://conductscience.org/library/papers/38616546PubMed
1133983836Cardiac Energy Metabolism in Heart Failure.Circ Res2021https://conductscience.org/library/papers/33983836PubMed
1240195182MLKL-Mediated Necroptosis Predominantly Contributes to Immune-Associated Myocardial Damage.Inflammation2025https://conductscience.org/library/papers/40195182PubMed
1339600110Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy.ESC Heart Fail2025https://conductscience.org/library/papers/39600110PubMed
1440461989Emerging role of the cGAS-STING pathway in cardiovascular diseases: biologic function, mechanisms and targeted therapy.Mol Med2025https://conductscience.org/library/papers/40461989PubMed
1534895860A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction.JACC Heart Fail2022https://conductscience.org/library/papers/34895860PubMed
1640394351METTL3-mediated m⁶A methylation in cardiac diseases: pathogenic roles and therapeutic potential.Cell Biol Toxicol2025https://conductscience.org/library/papers/40394351PubMed
1732694759Mitochondrial Ca2+ regulation in the etiology of heart failure: physiological and pathophysiological implications.Acta Pharmacol Sin2020https://conductscience.org/library/papers/32694759PubMed
1839297138Reassessing the Mechanisms of PLN-R14del Cardiomyopathy: From Calcium Dysregulation to S/ER Malformation.JACC Basic Transl Sci2024https://conductscience.org/library/papers/39297138PubMed
1939446238Leukocyte infiltration and cross-talk with cardiomyocytes exploit intracellular stress pathways in dilated cardiomyopathy of idiopathic origin.Mol Biol Rep2024https://conductscience.org/library/papers/39446238PubMed
2041169425Autoimmune inflammation as a key risk factor for heart failure with preserved ejection fraction: the different types of inflammation driving to HFpEF.Front Med (Lausanne)2025https://conductscience.org/library/papers/41169425PubMed

See all 134 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42985589

GET https://conductscience.org/api/papers/v1/42985589/references?page=2